We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.48%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.8B
AUM Growth
+$629M
Cap. Flow
-$312M
Cap. Flow %
-2.1%
Top 10 Hldgs %
24.14%
Holding
917
New
50
Increased
256
Reduced
457
Closed
57

Top Buys

Rank Stock Value
1
VERU icon
Veru
VERU
+$53M
2
MELI icon
Mercado Libre
MELI
+$43.2M
3
DAR icon
Darling Ingredients
DAR
+$41.7M
4
JNJ icon
Johnson & Johnson
JNJ
+$33.7M
5
MET icon
MetLife
MET
+$31.1M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$46.1M
2
NKE icon
Nike
NKE
+$36.6M
3
ITW icon
Illinois Tool Works
ITW
+$35.8M
4
AAPL icon
Apple
AAPL
+$31.9M
5
GILD icon
Gilead Sciences
GILD
+$29.8M

Sector Composition

Rank Sector Weight
1 Healthcare 33.32%
2 Technology 22.84%
3 Financials 10.04%
4 Consumer Discretionary 7.69%
5 Industrials 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FWONK icon
576
Liberty Media Series C
FWONK
$25.8B
$1.8M 0.01%
31,100
+3,797
+14% +$217K
HUBS icon
577
HubSpot
HUBS
$12.7B
$1.78M 0.01%
6,173
-240
-4% -$68K
PAYC icon
578
Paycom
PAYC
$7.92B
$1.78M 0.01%
5,740
-1,421
-20% -$459K
SNAP icon
579
Snap
SNAP
$7.97B
$1.76M 0.01%
197,190
-134,407
-41% -$1.33M
HST icon
580
Host Hotels & Resorts
HST
$17.5B
$1.74M 0.01%
108,343
-576,575
-84% -$10.1M
IMGO
581
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
$1.73M 0.01%
+48,094
New +$1.2M
LRN icon
582
Stride
LRN
$4.11B
$1.69M 0.01%
54,142
– –
PARA
583
DELISTED
Paramount Global Class B
PARA
$1.69M 0.01%
100,294
-11,873
-11% -$218K
SJM icon
584
J.M. Smucker
SJM
$13.6B
$1.68M 0.01%
10,576
-937
-8% -$140K
L icon
585
Loews
L
$24.6B
$1.67M 0.01%
28,568
-3,930
-12% -$219K
RCI icon
586
Rogers Communications
RCI
$19B
$1.66M 0.01%
35,443
-4,346
-11% -$185K
DHI icon
587
D.R. Horton
DHI
$42.1B
$1.65M 0.01%
18,520
-10,426
-36% -$836K
NVR icon
588
NVR
NVR
$17.4B
$1.64M 0.01%
356
-390
-52% -$1.71M
STLD icon
589
Steel Dynamics
STLD
$37B
$1.64M 0.01%
16,778
-2,866
-15% -$276K
AGCO icon
590
AGCO
AGCO
$8.44B
$1.63M 0.01%
11,730
+6,870
+141% +$847K
WLY icon
591
John Wiley & Sons Class A
WLY
$2.84B
$1.61M 0.01%
40,133
-16,691
-29% -$699K
CNP icon
592
CenterPoint Energy
CNP
$29.1B
$1.6M 0.01%
53,360
-30,774
-37% -$895K
AKYA
593
DELISTED
Akoya BioSciences
AKYA
$1.55M 0.01%
162,300
-9,000
-5% -$111K
MGA icon
594
Magna International
MGA
$18.9B
$1.54M 0.01%
27,433
-4,547
-14% -$255K
PKG icon
595
Packaging Corp of America
PKG
$22.4B
$1.53M 0.01%
11,931
-1,388
-10% -$174K
NTAP icon
596
NetApp
NTAP
$33.9B
$1.5M 0.01%
24,952
-5,248
-17% -$348K
GIL icon
597
Gildan
GIL
$9.49B
$1.49M 0.01%
54,577
+1,498
+3% +$43.5K
UL icon
598
Unilever
UL
$143B
$1.49M 0.01%
26,324
-6,083
-19% -$326K
SHEL icon
599
Shell
SHEL
$245B
$1.48M 0.01%
+26,075
New +$1.44M
AIZ icon
600
Assurant
AIZ
$14.1B
$1.48M 0.01%
11,868
+771
+7% +$103K
22 23
24
25 26

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2022 Portfolio in Review

As of Q4 2022, Candriam SCA held 917 positions worth $14.8B, up 4.4% from $14.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q4 2022 filing shows 50 new, 256 increased, 457 reduced and 57 closed positions. Its largest new stake was Sarepta Therapeutics: 95,144 shares worth $12.3M. The largest sale was PepsiCo, an estimated $46.1M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2022 buy was Sarepta Therapeutics: 95,144 shares worth $12.3M.
  • Candriam SCA added most to Veru in Q4 2022, an estimated $53M increase.
  • Candriam SCA's biggest Q4 2022 reduction was PepsiCo, cutting an estimated $46.1M.
  • Candriam SCA fully exited Global Blood Therapeutics, Inc. in Q4 2022, selling an estimated $24.6M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.8B portfolio in Q4 2022.
  • Candriam SCA opened 50 new positions and closed 57 in Q4 2022.
  • Candriam SCA's portfolio value rose 4.4% quarter-over-quarter to $14.8B.

Based on Candriam SCA's 13F filing for Q4 2022, filed 13 Feb 2023.